The Problems of the Safety Evaluation of Biotechnology Derived Drugs

被引：0
|
作者：
L.CAPRINO
G.TOGNA
机构：
[1] Institute
[2] Institute of Medical pharmacology IV Chair of Pharmacology University of Rome "La Sapienza"
[3] P.le A.Moro 5
[4] 00185 Rome
[5] Italy
来源：
Biomedical and Environmental Sciences | 1993年 / 04期
关键词：
The Problems of the Safety Evaluation of Biotechnology Derived Drugs;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Recent years have witnessed rapid advances in the toxicologic assessment of biotechproducts.Safety assessment of a biotech product is a complex and multiple process.This includes a knowledge of its pharmaco-biological characteristics,and identifyingthe target patient population and the proposed clinical application. To make a decision on the safe human application(the products are administering tohumans for therapeutic purposes),besides the identity and purity of the final product,
引用
收藏
页码：413 / 418
页数：6
相关论文
共 50 条
  • [21] PROBLEMS IN THE EVALUATION OF DRUGS IN MAN
    MODELL, W
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1959, 11 (10) : 577 - 594
  • [22] Biotechnology-derived drugs: how far has Morocco come?
    Zaoui, Sanaa
    Habchane, Amal
    Khatem, Soukaina
    Alioua, Ayyoub
    [J]. PAN AFRICAN MEDICAL JOURNAL, 2022, 43
  • [23] Evaluation of the safety of crop products produced through biotechnology
    Parrott, Wayne
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
  • [24] Food safety evaluation of crops produced through biotechnology
    Chassy, BN
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION, 2002, 21 (03) : 166S - 173S
  • [25] SOME PROBLEMS OF FORMATION OF STRATEGIES AND EVALUATION IN THE SPHERE OF BIOTECHNOLOGY
    MRACEK, K
    MACHLEIDT, P
    [J]. FILOSOFICKY CASOPIS, 1985, 33 (03): : 389 - 393
  • [26] THE SAFETY AND HAZARDS OF BLOOD-DERIVED DRUGS
    GRABENSTEIN, JD
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1995, 52 (21) : 2448 - 2452
  • [27] THE PROBLEMS OF SAFETY AND COMPLIANCE WITH CONVENTIONAL ANTIDEPRESSANT DRUGS
    LADER, M
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 1983, 68 : 91 - 95
  • [28] Safety warnings issued for biotechnology derived pharmaceuticals approved since 1995
    Giezen, T. J.
    Mantel-Teeuwisse, A. K.
    Straus, S. M. J.
    Schellekens, H.
    Egberts, A. C. G.
    Leufkens, H. G. M.
    [J]. DRUG SAFETY, 2007, 30 (10) : 968 - 968
  • [29] Biotechnology safety
    Krimsky, S
    [J]. ENVIRONMENT, 1997, 39 (05): : 27 - 30
  • [30] SAFETY IN BIOTECHNOLOGY
    BERKOVITCH, I
    [J]. MANUFACTURING CHEMIST, 1986, 57 (08): : 51 - 51
12345